Predictors of Unplanned Hospitalizations in Patients With Nonmetastatic Lung Cancer During Chemotherapy.

This was a claims-data study, so it could not capture chemotherapy dose, performance status, psychosocial factors, or the clinical details behind each hospitalization. Cancer stage was missing for about 30% of cases, and stage was coded as Unknown more often in the nonhospitalized group, which could bias comparisons. The study could not show why younger age or lower comorbidity was associated with more hospitalizations because it did not measure treatment intensity or actual dose. The financial analysis used submitted charges and Medicare payments without cost-to-charge ratios, so it does not show true cost or patient financial burden. The cohort was limited to adults at least 66 years old with continuous Medicare Parts A and B coverage and no HMO, so results may not apply to younger patients or other insurance.

The supplied text does not state author conflicts of interest. The publication types list National Institutes of Health extramural research support.

Do not conclude that comorbidity protects patients from hospitalization. The paper found lower likelihood of initial unplanned hospitalization with higher comorbidity scores, but the authors call this unexpected and note that the nonhospitalized group appeared to present with more pre-existing illnesses at diagnosis.